GIGAMUNE

GigaMune is a San Francisco biotechnology company developing a pipeline of in vivo cell therapies for cancer and inherited blood disorders... GigaMune is developing in vivo cell therapies for multiple myeloma, acute myeloblastic leukemia (AML), and inherited blood disorders such as sickle cell disease... Our vision is to solve the manufacturing bottleneck by infusing virus-like gene delivery particles directly into patients.

Also known as: GigaMune Inc.

Primary location: San Francisco United States